Citas
WHO. Neurological Disorders: Public health challenges Jun 2011.
OLESEN J, GUSTAVSSON A, SVENSSON M, ET AL. The Economic cost of brain disorders in Europe. European Journal of Neurology 2012;19:155-162.
KARAMPAMPA K, GUSTAVSSON A, MILTEM-BURGER C, ET AL. Treatment Experience. Burden, and unmet needs (tribune) in multiple sclerosis study: the cost and utilities on MS patients in Canada. J Popul Ther Clin Pharmacol 2012;19: e-11-e25.
OLEEN-BURKEY M, CASTELLI-HALEY J, LAGE M, JOHNSON K. Burden of Multiple Sclerosis Relapse. Patient 2012;5:57-69.
JENNUM P, WANSCHER B, FREDERIKSEN J, KJELLBERG J. The socioeconomic consequences of MS: a controled national study. Eur Neuropsycopharma-col 2012;22:36-43. Epub 2011 Jun 12.
SANCHEZ JL, AGUIRRE C, ARCOS-BURGOS OM, ET AL. Prevalencia de la Esclerosis Múltiple en Colombia. Rev Neurol 2000;31:1101-1103.
TORO J, SARMIENTO OI, DÍAZ DEL CASTILLO A ET AL. Prevalence of multiple sclerosis in Bogotá, Colombia. Neuroepidemiology 2007;28:33-38.
PALACIO LG, RIVERA D, BUILES J, ET AL. Multiple Sclerosis in the tropics: genetic association to STRs loci spanning the HLA and TNF. Multiple Sclerosis 2002;8:249-255.
PUTZKI N, FISCHER J, GOTTWALD K, ET AL. Quality of life in 1000 patients with early relapsing-remiting multiple sclerosis. Eur J Neurol 2009;16:313-720.
CUBILLOS L, ALFONSO E. Análisis descriptivo preliminar de los recobros en el Sistema General de Seguridad Social en Salud. Ministerio de la Protección Social 2005. http://www.med-informatica.com/OBSERVAMED/PAT/RecobrosFosyga02a05_DocNewsNo16192DocumentNo4233.pdf (31.01.2011).
ROMERO M, ARANGO C. ALVIS N, SUÁREZ JC, DUQUE. A. Value Health 2011;14 (5 suppl1):548-550.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.